Effects of salidroside on atherosclerosis: potential contribution of gut microbiota
Much research describes gut microbiota in atherosclerotic cardiovascular diseases (ASCVD) for that the composition of the intestinal microbiome or its metabolites can directly participate in the development of endothelial dysfunction, atherosclerosis and its adverse complications. Salidroside, a nat...
Saved in:
Main Authors: | Si-Fan Fei (Author), Can Hou (Author), Fang Jia (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
by: Shengjie Yang, et al.
Published: (2021) -
The Role of Gut Microbiota in Atherosclerosis and Hypertension
by: Junli Ma, et al.
Published: (2018) -
Palmatine protects against atherosclerosis by gut microbiota and phenylalanine metabolism
by: Anlu Wang, et al.
Published: (2024) -
Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis
by: Jinpeng Jing, et al.
Published: (2023) -
The Enhanced Pharmacological Effects of Modified Traditional Chinese Medicine in Attenuation of Atherosclerosis Is Driven by Modulation of Gut Microbiota
by: Wenyan Ji, et al.
Published: (2020)